National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 2 of 2 Research Studies DisplayedHughes PM, Ramage M, Gigli KH
Assessing the cost-effectiveness of removing supervision requirements for nurse practitioners prescribing buprenorphine for opioid use disorder.
The purpose of this study was to evaluate the cost-effectiveness of full practice authority relative to restricted scope of practice for nurse practitioners (NPs) who intend to prescribe buprenorphine for opioid use disorder before implementation of the Mainstreaming Addiction Treatment Act and the Medication Access and Training Expansion Act (MAT/MATE) Acts. The study also examined scenarios modeling various implementations of MAT/MATE. A simulated cohort of 10,000 NPs went through a decision tree model with a 1-year time horizon. The results indicated that adoption of full practice authority for NPs may be cost-effective for increasing the available workforce for substance use treatment and for increasing the number of patients receiving buprenorphine.
AHRQ-funded; HS000032.
Citation: Hughes PM, Ramage M, Gigli KH .
Assessing the cost-effectiveness of removing supervision requirements for nurse practitioners prescribing buprenorphine for opioid use disorder.
J Nurs Regul 2023 Oct; 14(3):44-54. doi: 10.1016/S2155-8256(23)00112-6..
Keywords: Opioids, Substance Abuse, Behavioral Health, Provider: Nurse, Policy, Healthcare Costs
Treasure G, Anderson DM, Hatcher L
Plan selection, enrollee risk, and health spending on the Patient Protection and Affordable Care Act individual marketplaces, 2019.
This study’s goal was to describe individual Patient Protection and Affordable Care Act (ACA) marketplace enrollees’ metal tier selections by risk score and assess enrollees’ health spending by metal tier, risk score, and spending type. This retrospective, cross-sectional study analyzed claims data from the Wakely Consulting Group ACA database including enrollees with continuous, full-year enrollment in on-exchange or off-exchange ACA-qualified health plans during the 2019 contract year. Enrollment totals, total spending, and out-of-pocket cost were calculated, stratified by metal tier and the Department of Health and Human Services (HHS) Hierarchical Condition Category (HCC) risk score for 2019. Enrollment and claims data were obtained for 1,317,707 enrollees (53.5% female; mean age, 46.35 years) across all census areas, age groups, and sexes. Of this cohort, 34.6% were on plans with cost-sharing reductions (CSRs), 75.5% did not have an assigned HCC, and 84.0% submitted at least 1 claim. Enrollees were more likely to be classified in the top HHS-HCC risk quartile if they selected platinum (42.0%), gold (34.4%), or silver (29.7%) plans compared with enrollees in bronze plans (17.2%). Median total spending was lower among bronze plan enrollees ($593; interquartile range (IQR), $28-$2100) vs platinum ($4111; IQR, $992-$15,821) or gold ($2675; IQR, $728-$9070).
AHRQ-funded; HS026395.
Citation: Treasure G, Anderson DM, Hatcher L .
Plan selection, enrollee risk, and health spending on the Patient Protection and Affordable Care Act individual marketplaces, 2019.
JAMA Netw Open 2023 Mar; 6(3):e234529. doi: 10.1001/jamanetworkopen.2023.4529..
Keywords: Health Insurance, Healthcare Costs, Policy